The Sun Pharma stock rallied 3% today after the drug-maker offered to acquire 100% in the Israeli drug-firm Taro Pharma in which it has 66% stake. While the move got a thumbs-up from analysts, some of Taro’s large shareholders may play spoilsport, reports CNBC-TV18's Archana Shukla.
first published: Oct 19, 2011 10:11 pm
A collection of the most-viewed Moneycontrol videos.
Iran Rejects US Talks Again, Strait Of Hormuz Tensions Rise As Oil Route Risks Grow
PM Modi Targets Congress After Women Reservation Bill Defeat, Vows To Remove Obstacles | FULL SPEECH
Trump Claims Iran Will Never Shut Hormuz Again, Big Statement Raises Global Questions
AMIT SHAH FULL SPEECH: Amit Shah Addresses Lok Sabha on Reservation, Delimitation & Representation
